Position in ASND
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$2,982,196
+$2,367,852 QoQ
Shares Held
11,181
+288.1% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#140
of 307 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Diversify Advisory Services, LLC holds $27,989,725 across 15 Biotechnology names. ASND ranks #2 (10.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
22,168 | $11,011,510 | |
| 2 | ASND |
Ascendis Pharma A/S
This page
|
11,181 | $2,982,196 | |
| 3 | ABVX |
Abivax S.A.
|
20,817 | $2,774,073 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
33,976 | $2,659,301 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
7,956 | $2,514,812 | |
| 6 | ARGX |
Argenx SE
|
2,197 | $2,038,310 | |
| 7 | DBVT |
DBV Technologies S.A.
|
89,692 | $1,470,948 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,211 | $755,106 |
All Filings in ASND
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,982,196 | 11,181 | Shares | Sole | 2026-08-10 | |
| 2025-12-31 | $614,344 | 2,881 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $528,238 | 2,657 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $424,250 | 2,458 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $310,317 | 1,991 | Shares | Sole | 2025-05-05 | |
| No filing history on record for this holder in this stock. | ||||||